首页> 外文会议>Annual meeting of the Institute of Nuclear Materials Management >LEGISLATIVE ISSUES FOR IMPORTING NARCOTIC AND PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS INTO THE RUSSIAN FEDERATION
【24h】

LEGISLATIVE ISSUES FOR IMPORTING NARCOTIC AND PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS INTO THE RUSSIAN FEDERATION

机译:将麻醉性和精神性物质及其前体输入俄罗斯联邦的立法问题

获取原文

摘要

Importation of narcotics and psychotropic substances and their precursors into the Russian Federation (RF) even for official purposes (e.g., medical or legal drug testing) had, until recently, been prohibited. However, the RF Duma recently revised and enacted new federal laws and procedures permitting their importation for legitimate uses, requiring the certification of personnel and facilities as well as imposing strict and, as yet, untested importation guidelines. The RF Ministry of Defense (MOD) drug testing program, under its Personnel Reliability Program (PRP), regularly screens for illicit drug use those individuals with access to sensitive nuclear material. This requires confirmation of these types of drugs through testing using gas chromatography/mass spectrometry (GC/MS) reagents and standards now permitted but not currently registered for importation into the RF by the RF Ministry of Health. The reagents and standards to be used for drug abuse testing under the PRP belong to the RF List 1, which is similar to the U.S. Controlled Substances Act, Schedule 1, meaning a category of drugs not considered legitimate for medical use.This paper presents and discusses the processes and procedures required to import substances from List 1 into the RF from the one-time license to permit to an import authorization certificate and the associated Russian ministries and agencies involved. Issues and subsequent resolutions will be described, including the establishment of drug (standards) import quotas.
机译:直到最近,甚至禁止出于官方目的(例如,医学或合法药物测试)将麻醉药品和精神药物及其前体进口到俄罗斯联邦。但是,RF杜马(RF Duma)最近修订并颁布了新的联邦法律和程序,允许其合法进口,要求人员和设施的认证以及严格的,未经测试的进口准则。在其人员可靠性计划(PRP)下,RF国防部(MOD)的药物测试计划会定期筛查那些接触敏感核材料的个人的非法药物使用情况。这就要求通过使用气相色谱/质谱(GC / MS)试剂和目前允许但目前尚未由RF卫生部注册用于RF进口的标准进行测试来确认这些类型的药物。根据PRP进行药物滥用测试的试剂和标准属于RF清单1,与美国受控物质法案附表1相似,这意味着一类药物不被视为可合法用于医疗用途。讨论了从一次性许可证中将清单1中的物质进口到RF中所需的过程和程序,以允许获得进口授权证书以及相关的俄罗斯有关部委和机构。将描述问题和后续解决方案,包括建立药品(标准)进口配额。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号